Oscotec Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Seongnam Korea, Republic of (1998)

Organization Overview

First Clinical Trial
2015
NCT02717988
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Oscotec Inc.